Cofepris granted emergency clearance to use the Pfizer coronavirus vaccine on Friday.
2 min read
This story originally appeared at high level
The Undersecretary of State for Prevention and Health Promotion, Hugo Lopez-Gatell, announced that the vaccine Pfizer-BioNTech against the coronavirus COVID-19 received approval for emergencies from the Federal Commission for Prevention and Hygiene Risks (Cofepris).
This makes Mexico the fourth country, after the UK, Bahrain and Canada, to approve Pfizer’s vaccine against COVID-19.
Yesterday the advisory board of the FDA The United States supported the drug company’s use of the antigen, although it has not yet been officially approved by the agency.
On Tuesday, British citizens became the first in the world to receive doses of a COVID-19 formula for which extensive clinical studies have already been conducted.
The UK Medicines Agency advised people with a significant history of allergies not to vaccinate the Pfizer BioNTech vaccine against COVID-19 after two people reported serious side effects on the first day of launch.